
Feature|Videos|November 19, 2025
The Consequences: When a Guess Becomes a Gamble
Author(s)David Edelman, Thrivable
Learn how outdated or incomplete insights turn every decision into a high-stakes gamble that cost brands money, momentum, and internal alignment.
Advertisement
When leaders rely on old data or partial truths, the fallout can be brutal. Budgets get wasted solving the wrong problem, like targeting market access when the real issue is patient confusion. Opportunities vanish as competitors seize openings before lagging data confirms them. Without a single, trusted source of patient truth, teams lock up in decision paralysis, battle over opinions, and allow the “loudest voice” to dictate strategy. Momentum stalls, alignment fractures, and the brand pays the price.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5





